These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11413601)

  • 1. Erythromycin enhances oesophageal motility in patients with gastro-oesophageal reflux.
    Chrysos E; Tzovaras G; Epanomeritakis E; Tsiaoussis J; Vrachasotakis N; Vassilakis JS; Xynos E
    ANZ J Surg; 2001 Feb; 71(2):98-102. PubMed ID: 11413601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ABT-229, a motilin agonist, on acid reflux, oesophageal motility and gastric emptying in patients with gastro-oesophageal reflux disease.
    Netzer P; Schmitt B; Inauen W
    Aliment Pharmacol Ther; 2002 Aug; 16(8):1481-90. PubMed ID: 12182748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cisapride on nocturnal transient lower oesophageal sphincter relaxations and nocturnal gastro-oesophageal reflux in patients with oesophagitis: a double-blind, placebo-controlled study.
    Pehlivanov N; Sarosiek I; Whitman R; Olyaee M; McCallum R
    Aliment Pharmacol Ther; 2002 Apr; 16(4):743-7. PubMed ID: 11929392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisapride in gastro-oesophageal reflux disease: effects on oesophageal motility and intra-oesophageal pH.
    Wienbeck M; Li Q
    Scand J Gastroenterol Suppl; 1989; 165():13-8; discussion 27-8. PubMed ID: 2690320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of intravenous erythromycin on esophageal motility in healthy subjects.
    Tzovaras G; Xynos E; Chrysos E; Mantides A; Vassilakis JS
    Am J Surg; 1996 Mar; 171(3):316-9. PubMed ID: 8615464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of motilin agonist ABT-229 on gastro-oesophageal reflux, oesophageal motility and lower oesophageal sphincter characteristics in GERD patients.
    Van Herwaarden MA; Samsom M; Van Nispen CH; Verlinden M; Smout AJ
    Aliment Pharmacol Ther; 2000 Apr; 14(4):453-62. PubMed ID: 10759625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 24-hour oesophageal motility in gastro-oesophageal reflux disease (GORD): increased occurrence of simultaneous contractions.
    Bittinger M; Barnert J; Demharter R; Wienbeck M
    Eur J Gastroenterol Hepatol; 1996 Mar; 8(3):201-4. PubMed ID: 8724017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of non-selective gamma-aminobutyric acid receptor stimulation on motor function of the lower oesophageal sphincter and gastro-oesophageal reflux in healthy human subjects.
    Cantù P; Carmagnola S; Savojardo D; Allocca M; Penagini R
    Aliment Pharmacol Ther; 2003 Oct; 18(7):699-704. PubMed ID: 14510743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of cisapride on oesophageal motility and lower sphincter function in patients with gastro-oesophageal reflux disease.
    Finizia C; Lundell L; Cange L; Ruth M
    Eur J Gastroenterol Hepatol; 2002 Jan; 14(1):9-14. PubMed ID: 11782569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: a 24 hour ambulatory combined pH and manometry study.
    Inauen W; Emde C; Weber B; Armstrong D; Bettschen HU; Huber T; Scheurer U; Blum AL; Halter F; Merki HS
    Gut; 1993 Aug; 34(8):1025-31. PubMed ID: 8174947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oesophageal motility defects associated with nocturnal gastro-oesophageal reflux on proton pump inhibitors.
    Fouad YM; Katz PO; Castell DO
    Aliment Pharmacol Ther; 1999 Nov; 13(11):1467-71. PubMed ID: 10571603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of cholecystokinin antagonism on postprandial lower oesophageal sphincter function in asymptomatic volunteers and patients with reflux disease.
    Trudgill NJ; Hussain FN; Moustafa M; Ajjan R; D'Amato M; Riley SA
    Aliment Pharmacol Ther; 2001 Sep; 15(9):1357-64. PubMed ID: 11552906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholinergic blockade inhibits gastro-oesophageal reflux and transient lower oesophageal sphincter relaxation through a central mechanism.
    Fang JC; Sarosiek I; Yamamoto Y; Liu J; Mittal RK
    Gut; 1999 May; 44(5):603-7. PubMed ID: 10205193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the supplementation of the formula with fibre increase the risk of gastro-oesophageal reflux during enteral nutrition? A human study.
    Bouin M; Savoye G; Hervé S; Hellot MF; Denis P; Ducrotté P
    Clin Nutr; 2001 Aug; 20(4):307-12. PubMed ID: 11478827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisapride: influence on oesophageal and gastric emptying and gastro-oesophageal reflux in patients with reflux oesophagitis.
    Collins BJ; Spence RA; Ferguson R; Laird J; Love AH
    Hepatogastroenterology; 1987 Jun; 34(3):113-6. PubMed ID: 3301606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of erythromycin on human esophageal motility is mediated by serotonin receptors.
    Koutsoumbi P; Epanomeritakis E; Tsiaoussis J; Athanasakis H; Chrysos E; Zoras O; Vassilakis JS; Xynos E
    Am J Gastroenterol; 2000 Dec; 95(12):3388-92. PubMed ID: 11151866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oesophageal motor responses to gastro-oesophageal reflux in healthy controls and reflux patients.
    Anggiansah A; Taylor G; Marshall RE; Bright NF; Owen WA; Owen WJ
    Gut; 1997 Nov; 41(5):600-5. PubMed ID: 9414964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is motility impaired in the entire upper gastrointestinal tract in patients with gastro-oesophageal reflux disease?
    Lundell L; Myers JC; Jamieson GG
    Scand J Gastroenterol; 1996 Feb; 31(2):131-5. PubMed ID: 8658034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a 5-HT(4) receptor agonist on oesophageal function and gastro-oesophageal reflux: studies using combined impedance-manometry and combined impedance-pH.
    Tutuian R; Mainie I; Allan R; Hargreaves K; Agrawal A; Freeman J; Gale J; Castell DO
    Aliment Pharmacol Ther; 2006 Jul; 24(1):155-62. PubMed ID: 16803614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of atropine on gastro-oesophageal reflux and transient lower oesophageal sphincter relaxations in patients with gastro-oesophageal reflux disease.
    Lidums I; Checklin H; Mittal RK; Holloway RH
    Gut; 1998 Jul; 43(1):12-6. PubMed ID: 9771399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.